Blog
What does the new FDA guidance mean for clinical trials in early Alzheimer’s disease?
The latest FDA draft guidance for clinical trials in early Alzheimer’s disease presents many new opportunities and challenges for drug development.
WEBINAR: Finding the right patients for clinical trials in early Alzheimer's disease
Dr Kenton Zavitz, Director of Clinical Affairs at Cambridge Cognition, and Dr Robert Smith, Consultant Neuropsychologist, hosted a webinar to discuss clinical trials for early Alzheimer’s disease.
Join them to hear more about overcoming the barriers to expedite the drug development process.
Tuesday 22nd May 2018, 11 a.m. EDT
web-based testing,
wearables,
voice recognition,
voice,
virtual clinical trials,
technology,
swm,
stress,
social cognition,
smartphones,
schizophrenia,
safety,
rvp,
rti,
research funding,
research,
remote testing,
recruitment,
psychosis,
prodromal,
pro-cognitive,
prm,
press release,
presenteeism,
precision psychiatry,
poster,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
ots,
occupational health,
nutrition,
neuroscience,
near-patient testing,
multiple sclerosis,
mts,
ms,
mental wellbeing,
mental health,
mdd,
mci,
major depression,
machine learning,
life at cambridge cognition,
jobs at cambridge cognition,
international women's day,
ied,
hot cognition,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
emotion recognition,
ecoa,
ebt,
early career researchers,
early alzheimer's disease,
dms,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive testing,
cognitive science,
cognitive safety,
cognitive research,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab for clinical trials,
cantab,
cambridge cognition,
brain health,
bipolar disorder,
biomarkers,
automatic speech recognition,
attention,
alzheimer's disease,
affective cognition,
academic,
absenteeism,
aaic2020,
aaic,
